30982 Federal Register / Vol. 86, No. 110 / Thursday, June 10, 2021 / Notices 

Management Ltd, London, UNITED 

KINGDOM; Ameren Services, St. Louis, 

MO; Anterix, Woodland Park, NJ; ATT 

Business, Dallas, TX; BEC Technologies, 

Richardson, TX; Blinq Network, 

Markham, CANADA; Bridgewater 

Group Consulting, Irvine, CA; Burns 

and McDonnell, Kansas City, MO; Cisco, 

San Jose, CA; Council Rock, Rochester, 

NY; CrescoNet, San Francisco, CA; 

Encore Networks, Chantilly, VA; 

Ericsson, Plano, TX; Evergy, Kansas 

City, MO; GE Industrial 

Communications, Rochester, NY; 

Hitachi-ABB, Raleigh, NC; JEA, 

Jacksonville, FL; K and A Engineering, 

White Plains, NY; L3 Harris, Rochester, 

NY; Mimomax Wireless, Christchurch, 

NEW ZEALAND; Motorola Solutions, 

Chicago, IL; Multi Tech Systems, 

Mounds View, MN; Nokia, Coppell, TX; 

NovaTech, Lenexa, KS; National Rural 

Telecommunications Cooperative, 

Herndon, VA; NY Power Authority 

(NYPA), White Plains, NY; Palmetto 

Technology Associates, Kiawah Island, 

SC; Puloli, Inc., San Francisco, CA; 

Southern California Edison, Rosemead, 

CA; SouthernLinc, Atlanta, GA; Telit 

Wireless Solutions, Durham, NC; World 

Wide Technology, Maryland Heights, 

MO; and Xcel Energy, Minneapolis, MN. 

UBBA was formed as a Delaware nonstock member corporation. The general 

area of UBBA’s planned activity is to 

empower utilities and ecosystem 

partners to champion the development 

of utility broad-band networks as a key 

enabler of the utility of the future, and 

to undertake such other activities as 

may from time to time be appropriate to 

further the purposes and achieve the 

goals set forth above. 

Membership in UBBA remains open 

and UBBA intends to file additional 

written notifications disclosing all 

changes in membership. 

Suzanne Morris, 

Chief, Premerger and Division Statistics, 

Antitrust Division. 

[FR Doc. 2021–12180 Filed 6–9–21; 8:45 am] 

BILLING CODE 4410–11–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–847] 

Importer of Controlled Substances 

Application: Cambrex Charles City 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Cambrex Charles City has 

applied to be registered as an importer 

of basic class(es) of controlled 

substance(s). Refer to Supplemental 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before July 12, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

July 12, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for a hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on May 6, 2021, Cambrex 

Charles City, 1205 11th Street, Charles 

City, Iowa 50616–3466, applied to be 

registered as an importer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

4-Anilino-N-Phenethyl4-Piperidine (ANPP).8333 II 

Phenylacetone .............. 8501 II 

Coca leaves .................. 9040 II 

Opium, raw ................... 9600 II 

Poppy Straw Concentrate.9670 II 

The company plans to import the 

listed controlled substances for internal 

use and to bulk manufacture other 

controlled substances in Active 

Pharmaceutical Ingredient (API) form 

for distribution to its customers. No 

other activity for these drug codes is 

authorized for this registration. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–12215 Filed 6–9–21; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–844] 

Importer of Controlled Substances 

Application: Fisher Clinical Services, 

Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Fisher Clinical Services, Inc. 

has applied to be registered as an 

importer of basic class(es) of controlled 

substance(s). Refer to Supplemental 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before July 12, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

July 12, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for a hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on May 17, 2021, Fisher 

Clinical Services, Inc. 7554 Schantz 

Road, Allentown, Pennsylvania 18106– 

9032 applied to be registered as an 

importer of the following basic class(es) 

of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Marihuana Extract ........ 7350 I 

The company plans to import the listed 

controlled substances for clinical trails 

only. No other activity for these drug 

codes is authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 


khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 86, No. 110 / Thursday, June 10, 2021 / Notices 30983 

import of the Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–12212 Filed 6–9–21; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–845] 

Bulk Manufacturer of Controlled 

Substances Application: Bulk 

Manufacturer of Marihuana: Maridose, 

LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: The Drug Enforcement 

Administration (DEA) is providing 

notice of an application it has received 

from an entity applying to be registered 

to manufacture in bulk basic class(es) of 

controlled substances listed in schedule 

I. DEA intends to evaluate this and other 

pending applications according to its 

regulations governing the program of 

growing marihuana for scientific and 

medical research under DEA 

registration. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefor, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before August 9, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW 8701 

Morrissette Drive, Springfield, Virginia 

22152. To ensure proper handling of 

comments, please reference Docket 

No—DEA–845 in all correspondence, 

including attachments. 

SUPPLEMENTARY INFORMATION: The 

Controlled Substances Act (CSA) 

prohibits the cultivation and 

distribution of marihuana except by 

persons who are registered under the 

CSA to do so for lawful purposes. In 

accordance with the purposes specified 

in 21 CFR 1301.33(a), DEA is providing 

notice that the entity identified below 

has applied for registration as a bulk 

manufacturer of schedule I controlled 

substances. In response, registered bulk 

manufacturers of the affected basic 

class(es), and applicants therefor, may 

file written comments on or objections 

of the requested registration, as 

provided in this notice. This notice does 

not constitute any evaluation or 

determination of the merits of the 

application submitted. 

The applicant plans to manufacture 

bulk active pharmaceutical ingredients 

(APIs) for product development and 

distribution to DEA registered 

researchers. If the application for 

registration is granted, the registrant 

would not be authorized to conduct 

other activity under this registration 

aside from those coincident activities 

specifically authorized by DEA 

regulations. DEA will evaluate the 

application for registration as a bulk 

manufacturer for compliance with all 

applicable laws, treaties, and 

regulations and to ensure adequate 

safeguards against diversion are in 

place. 

As this applicant has applied to 

become registered as a bulk 

manufacturer of marihuana, the 

application will be evaluated under the 

criteria of 21 U.S.C. 823(a). In addition 

to seeking to produce marihuana 

extract, this applicant is separately 

seeking to cultivate marihuana. See 

Notice of Application, Bulk 

Manufacturers of Marihuana, 84 FR 

44920, 44922 (Aug. 27, 2019). DEA thus 

will conduct this evaluation in the 

manner described in the rule published 

at 85 FR 82333 on December 18, 2020, 

and reflected in DEA regulations at 21 

CFR part 1318. 

In accordance with 21 CFR 

1301.33(a), DEA is providing notice that 

on May 6, 2021, Maridose, LLC., 74 

Orion Street, Brunswick, Maine 04011, 

applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substances: 

Controlled substance Drug 

code Schedule 

Marihuana Extract ........ 7350 I 

William T. McDermott, 

Assistant Administrator. 

[FR Doc. 2021–12213 Filed 6–9–21; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–843] 

Importer of Controlled Substances 

Application: National Center for 

Natural Products Research 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: National Center for Natural 

Products Research has applied to be 

registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to SUPPLEMENTARY INFORMATION

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before July 12, 2021. Such persons 

may also file a written request for a 

hearing on the application on or before 

July 12, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All request for a hearing 

should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on April 14, 2021, 

National Center for Natural Products 

Research, 806 Hathorn Road, 135 Coy 

Waller Lab, University, Mississippi 

38677–1848, applied to be registered as 

an importer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Marihuana Extract .......... 7350 I 

Marihuana ....................... 7360 I 

Tetrahydrocannabinols ... 7370 I 

The company plans to acquire new 

genetic materials with improved 

Cannabinoids for research and 

manufacturing purposes. No other 

activity for these drug codes is 

authorized for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of FDA-approved or nonVerDate Sep<11>2014 17:15 Jun 09, 2021 Jkt 253001 PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 E:\FR\FM\10JNN1.SGM 10JNN1

khammond on DSKJM1Z7X2PROD with NOTICES

I I